BIA
TMO icon

Benchmark Investment Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Benchmark Investment Advisors’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$227K Buy
+462
New +$251K 0.13% 72
2025
Q3 		$230K Buy
+475
New +$221K 0.13% 74
2025
Q1 		$270K Sell
544
-69
-11% -$37.4K 0.18% 80
2024
Q4 		$319K Sell
613
-43
-7% -$23.6K 0.21% 71
2024
Q3 		$406K Sell
656
-900
-58% -$533K 0.29% 63
2024
Q2 		$861K Sell
1,556
-10
-0.6% -$5.73K 0.62% 40
2024
Q1 		$910K Sell
1,566
-374
-19% -$210K 0.72% 39
2023
Q4 		$1.03M Sell
1,940
-1,470
-43% -$712K 0.95% 33
2023
Q3 		$1.73M Sell
3,410
-207
-6% -$110K 1.74% 19
2023
Q2 		$1.89M Buy
3,617
+59
+2% +$31.8K 1.74% 17
2023
Q1 		$2.05M Sell
3,558
-107
-3% -$60.3K 2.11% 13
2022
Q4 		$2.02M Sell
3,665
-218
-6% -$116K 2.13% 13
2022
Q3 		$1.97M Buy
3,883
+31
+0.8% +$17.3K 2.12% 14
2022
Q2 		$2.09M Buy
3,852
+21
+0.5% +$11.6K 2.18% 11
2022
Q1 		$2.26M Buy
3,831
+1,591
+71% +$914K 1.7% 12
2021
Q4 		$1.5M Buy
+2,240
New +$1.4M 1.23% 26

Other funds holding TMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Benchmark Investment Advisors's TMO Position: Q1 2026 in Review

Benchmark Investment Advisors opened a new position in Thermo Fisher Scientific (TMO) in Q1 2026: 462 shares worth $227K. The stake represents 0.13% of the portfolio and ranks #72 among its holdings. This is a return to the name: Benchmark Investment Advisors previously reported a position in TMO as recently as Q3 2025.

Benchmark Investment Advisors first reported a position in TMO in Q4 2021 and has held it in 16 quarters since. The position peaked at $2.26M in Q1 2022. 2,590 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Benchmark Investment Advisors held 462 shares of Thermo Fisher Scientific worth $227K as of Q1 2026.
  • Thermo Fisher Scientific was a new Benchmark Investment Advisors position in Q1 2026.
  • Thermo Fisher Scientific made up 0.13% of Benchmark Investment Advisors's portfolio in Q1 2026, its #72 holding.
  • Benchmark Investment Advisors first reported a position in Thermo Fisher Scientific in Q4 2021 and has held it in 16 quarters since.
  • Benchmark Investment Advisors's Thermo Fisher Scientific position peaked at $2.26M in Q1 2022.
  • 2,590 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Benchmark Investment Advisors's 13F filing for Q1 2026, filed 13 May 2026.